Ajanta Pharma Limited, v. National Pharmaceuticals
Case brief
What is this about?
Bombay High Court consent decree in a pharmaceutical intellectual-property rights suit: Ajanta Pharma Limited (plaintiff) v. National Pharmaceuticals (defendants); consent terms dated 25 March 2026 taken on record, marked 'X'; undertakings accepted as undertakings to the court; leave under Clause 14 of the Letters Patent granted (Leave Petition No. 69 of 2026, prayer clause 'a'); suit decreed in terms of consent terms; formal decree drawing-up dispensed with; IA No. 3888 of 2024 (printed as 388 of 2024) infructuous; compliance listing 27 April 2026 ('for directions'); coram Gauri Godse J.; decided 7 April 2026; advocates: Ashutosh Kane, Kanak Kadam (plaintiff), Priyanka Prabhakar (defendants).
What did the court decide?
Suit decreed in terms of the consent terms dated 25th March 2026, with the assurances and undertakings therein accepted as undertakings to the court; drawing up of a formal decree dispensed with; Leave Petition No. 69 of 2026 allowed in terms of prayer clause ‘a’ (grant of leave under Clause 14 of the Letters Patent); Interim Application No. 3888 of 2024 disposed as infructuous; suit to be listed for recording compliance on 27th April 2026 under the caption ‘for directions’.